Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |
mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |